Novartis (NVS) revenue

Revenue · fiscal 2025
$56.67B

Novartis (NVS) reported revenue of $56.67B in fiscal 2025 (the year ended December 31, 2025). That is 9.6% higher than the $51.72B of fiscal 2024. Figures as of 18 Nov 2026, 09:43 UTC, from Yahoo Finance.

Key facts

Revenue, fiscal 2025
$56.67B
Change on fiscal 2024
+9.6%
Highest on record
$56.67Bfiscal 2025
Lowest on record
$43.46Bfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

Novartis revenue, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $56.67B in fiscal 2025 and the lowest $43.46B in fiscal 2022.

History · 4 fiscal years

Revenue by fiscal year

Novartis revenue, year by year

Novartis (NVS) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$56.67B 9.6% up
2024$51.72B 10.8% up
2023$46.66B 7.4% up
2022$43.46B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Novartis and comparable companies
CompanyRevenueFiscal year
AbbVie ABBV$61.16B2025
Merck & Co MRK$65.01B2025
UnitedHealth Group UNH$447.57B2025
Novartis NVS$56.67B2025
AstraZeneca AZN$58.74B2025
Thermo Fisher Scientific TMO$44.56B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on NVS

Novartis, figure by figure

Novartis (NVS) overview: price, valuation and scorecardAll health care companies by market value

Novartis revenue: questions and answers

What is Novartis's revenue?

Novartis (NVS) reported revenue of $56.67B in fiscal 2025 (the year ended December 31, 2025). That is 9.6% higher than the $51.72B of fiscal 2024.

What are the highest and lowest revenue figures on record for Novartis?

Across the 4 fiscal years on record (2022–2025), the highest was $56.67B in fiscal 2025 and the lowest $43.46B in fiscal 2022.

How is Novartis's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Novartis it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Novartis (NVS) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/NVS/revenue

Underlying data: Yahoo Finance.